6533b81ffe1ef96bd127874c

RESEARCH PRODUCT

Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction

Luis Rodríguez-padialMercè RoquéIrene R. DéganoPedro Morrondo ValdeolmillosBerta Vega-hernandezDavid Garcia-doradoIñaki LekuonaPedro L. SánchezRosa-maria LidónAntonio MayorgaSilvia Pérez-fernándezJoan VilaAlberto NúñezJaume MarrugatJosé A. BarrabésDaniel Bosch-portellAntonio Sanchez-hidalgoJulio Martí-almorJulio Martí-almorFrancisco Fernández-avilésAndres Carrillo-lopezManuel F. Jiménez-navarroDaniel Fernández-bergésMarcos Rodríguez EstebanRoberto ElosuaLaura QuintasJavier Alameda SerranoEmad Abu AssiReyes Gonzalez FernandezJose Manuel Garcia RuizLuis Martínez DolzAne ElorriagaAlessandro SionisJessica VaqueroAntoni Bayes-genisEsther Sanchez-insaCatalina RubertVicente Bertomeu-gonzalezIsaac SubiranaAlberto ZamoraLuis Ruiz-valdepeñasJuan Sanchis

subject

MaleTime FactorsPercutaneoussistema de registrosmedicine.medical_treatmenthumanosComorbidityCoronary Artery Disease030204 cardiovascular system & hematologyLogistic regression0302 clinical medicineRecurrenceRisk Factorsevaluación de riesgosST segmentRegistries1506030212 general & internal medicineMyocardial infarctionAged 80 and overancianocoronary intervention (PCI)resultado del tratamientoCardiogenic shockAge FactorsShockstemiTreatment Outcomesurgical procedures operativeCardiologyFemaleAcute coronary syndromeCardiology and Cardiovascular MedicineStemiAcute coronary syndromemedicine.medical_specialtyShock CardiogenicPulmonary EdemaRisk Assessmentacute coronary syndromeedema pulmonar03 medical and health sciencesfactores de tiempoPercutaneous Coronary Interventionchoquecirugía coronaria percutáneaInternal medicinemedicinefactores de riesgoHumanscardiovascular diseasesAgedCoronary intervention (PCI)business.industryPercutaneous coronary interventionmedicine.diseaseSpainPropensity score matchingST Elevation Myocardial Infarctionbusinessrecurrencia

description

Objective Primary percutaneous coronary intervention (P-PCI) has demonstrated its efficacy in patients with ST segment elevation myocardial infarction (STEMI). However, patients with STEMI >= 75 years receive less P-PCI than younger patients despite their higher in-hospital morbimortality. The objective of this analysis was to determine the effectiveness of P-PCI in patients with STEMI >= 75 years. Methods We included 979 patients with STEMI >= 75 years, from the ATencion HOspitalaria del Sindrome coronario study, a registry of 8142 consecutive patients with acute coronary syndrome admitted at 31 Spanish hospitals in 2014-2016. We calculated a propensity score (PS) for the indication of P-PCI. Patients that received or not P-PCI were matched by PS. Using logistic regression, we compared the effectiveness of performing P-PCI versus non-performance for the composite primary event, which included death, reinfarction, acute pulmonary oedema or cardiogenic shock during hospitalisation. Results Of the included patients, 81.5 % received P-PCI. The matching provided two groups of 169 patients with and without P-PCI. Compared with its non-performance, P-PCI presented a composite event OR adjusted by PS of 0.55 (95% CI 0.34 to 0.89). Conclusions Receiving a P-PCI was significantly associated with a reduced risk of major intrahospital complications in patients with STEMI aged 75 years or older.

https://doi.org/10.1136/openhrt-2019-001169